Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis

References

• KanisJADiagnosis of osteoporosisOsteoporosis Int19977S3S108S116
   PubMed Web of Science ®Google Scholar
• SimsNAMartinTJCoupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unitBonekey Rep2014348124466412
   PubMedGoogle Scholar
• BurgeRDawson-HughesBSolomonDHWongJBKingATostesonAIncidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025J Bone Miner Res200722346547517144789
   PubMed Web of Science ®Google Scholar
• KvienTKHaugebergGUhligTData driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk of osteoporosisAnn Rheum Dis2000591080581111005782
   PubMed Web of Science ®Google Scholar
• LodderMCHaugebergGLemsWFOslo-Truro-Amsterdam (OSTRA) Collaborative StudyRadiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative studyArthritis Rheum200349220921512687512
   PubMed Web of Science ®Google Scholar
• HaugebergGUhligTFalchJAHalseJIKvienTKBone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis registerArthritis Rheum200043352253010728744
   PubMed Web of Science ®Google Scholar
• DimitroulasTNikasSNTrontzasPKitasGDBiologic therapies and systemic bone loss in rheumatoid arthritisAutoimmun Rev2013121095896623542506
   PubMed Web of Science ®Google Scholar
• HolickMFVitamin D deficiencyN Engl J Med2007357326628117634462
   PubMed Web of Science ®Google Scholar
• MorrisHAVitamin D activities for health outcomesAnn Lab Med201434318118624790904
   PubMed Web of Science ®Google Scholar
• LipsPGielenEvan SchoorNMVitamin D supplements with or without calcium to prevent fracturesBonekey Rep2014351224818004
   PubMedGoogle Scholar
• EbelingPRVitamin D and bone health: Epidemiologic studiesBonekey Rep2014351124818003
   PubMedGoogle Scholar
• TanLMLongTTGuanXLDiagnostic Value of Vitamin D Status and Bone Turnover Markers in Rheumatoid Arthritis Complicated by OsteoporosisAnn Clin Lab Sci201848219720429678847
   PubMed Web of Science ®Google Scholar
• BlackDMBauerDCSchwartzAVCummingsSRRosenCJContinuing bisphosphonate treatment for osteoporosis – for whom and for how long?N Engl J Med2012366222051205322571169
   PubMed Web of Science ®Google Scholar
• BoneHGWagmanRBBrandiML10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extensionLancet Diabetes Endocrinol20175751352328546097
   PubMed Web of Science ®Google Scholar
• NakamuraYSuzukiTKamimuraMVitamin D and calcium are required at the time of denosumab administration during osteoporosis treatmentBone Res201751702129021920
   PubMed Web of Science ®Google Scholar
• SoenSNew Diagnostic Criteria and Guidelines on Osteoporosis. Diagnostic criteria for primary osteoporosis: year 2012 revision. (Article in Japanese)Clin Calcium20142432332924576928
   PubMedGoogle Scholar
• van der LindenMPKnevelRHuizingaTWvan der Helm-van MilAHClassification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteriaArthritis Rheum2011631374220967854
   PubMed Web of Science ®Google Scholar
• KamimuraMTaguchiANakamuraYPretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapyTher Clin Risk Manag20181463764229662314
   PubMed Web of Science ®Google Scholar
• RouxCBinkleyNBoonenSFOCUS-D InvestigatorsVitamin D status and bone mineral density changes during alendronate treatment in postmenopausal osteoporosisCalcif Tissue Int201494215315723912950
   PubMed Web of Science ®Google Scholar
• WongTHGuptaEDRadhakrishnanAKGunSCChembalingamGYeapSSEffects of 25-hydroxyvitamin D and vitamin D-binding protein on bone mineral density and disease activity in Malaysian patients with rheumatoid arthritisInt J Rheum Dis2018215992100028217867
   PubMed Web of Science ®Google Scholar
• KhashayarPAghaei MeybodiHRRezai HemamiMKeshtkarADimaiHPLarijaniBVitamin D status and its relationship with bone mineral density in a healthy Iranian populationRev Bras Ortop201651445445827517026
   PubMedGoogle Scholar
• KharroubiASabaESmoomRBaderKDarwishHSerum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal womenArch Osteoporos20171211328124221
   PubMed Web of Science ®Google Scholar
• NakamuraYUchiyamaSKamimuraMIkegamiSKomatsuMKatoHIncreased Serum 25(OH)D3 Levels in Post-Menopausal Japanese Women with Osteoporosis after 3-Year Bisphosphonate TreatmentTohoku J Exp Med2017242324124628740036
   PubMed Web of Science ®Google Scholar
• KamimuraMUchiyamaSNakamuraYIkegamiSMukaiyamaKKatoHShort-term bisphosphonate treatment reduces serum 25(OH) vitamin D3 and alters values of parathyroid hormone, pentosidine, and bone metabolic markersTher Clin Risk Manag20171316116828243105
   PubMed Web of Science ®Google Scholar
• AugouleaATsakonasETriantafyllopoulosIComparative effects of denosumab or bisphosphonate treatment on bone mineral density and calcium metabolism in postmenopausal womenJ Musculoskelet Neuronal Interact201717144444928250248
   PubMed Web of Science ®Google Scholar
• FleetJCThe role of vitamin D in the endocrinology controlling calcium homeostasisMol Cell Endocrinol2017453364528400273
   PubMed Web of Science ®Google Scholar
• NakamuraYKamimuraMIkegamiSChanges in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: a short-term studyBMC Endocr Disord2015158126666998
   PubMed Web of Science ®Google Scholar
• MartinsJSPalharesMOTeixeiraOCGontijo RamosMVitamin D Status and Its Association with Parathyroid Hormone Concentration in BraziliansJ Nutr Metab20172017905647028265467
   PubMed Web of Science ®Google Scholar
• WintermeyerEIhleCEhnertSCrucial Role of Vitamin D in the Musculoskeletal SystemNutrients201686E31927258303
   PubMed Web of Science ®Google Scholar
• KinoshitaMIshijimaMKanekoHThe increase in bone mineral density by bisphosphonate with active vitamin D analog is associated with the serum calcium level within the reference interval in postmenopausal osteoporosisMod Rheumatol Epub201893
   Web of Science ®Google Scholar
• FavusMJGoltzmanDRegulation of calcium and magnesiumRosenCJPrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism8th edHoboken, NJJohn Wiley & Sons2013172179
   Google Scholar
• SuzukiTNakamuraYKatoHChanges of Bone-Related Minerals during Denosumab Administration in Post-Menopausal Osteoporotic PatientsNutrients201798E87128805705
   PubMed Web of Science ®Google Scholar
• SuzukiTNakamuraYKatoHDetermination of serum bone-related minerals during denosumab treatment in osteoporosis patients with rheumatoid arthritisClin Nutr ESPEN201826535629908683
   PubMed Web of Science ®Google Scholar
• NakamuraYSuzukiTKatoHDenosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis: Denosumab improves bone mineral density in osteoporosis with rheumatoid arthritisArch Osteoporos20171218028936606
   PubMed Web of Science ®Google Scholar